{"schema_version":"secwatch.filing_event.v1","accession":"0000310158-26-000237","form_type":"8-K","ticker":"MRK","cik":"0000310158","company_name":"Merck & Co., Inc.","filed_at":"2026-10-13T16:36:57+00:00","discovered_at":"2026-10-13T16:38:00.088637+00:00","generated_at":"2026-10-13T16:38:02.826162+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Merck elects Paul J. Diaz to board effective Nov. 1, 2026; board grows to 14 members","bullets":["Paul J. Diaz, managing partner at Cressey & Company, joins Merck's board effective Nov. 1, 2026 and will stand for shareholder election in May 2027.","Diaz was appointed to both the Audit Committee and the Research Committee of the board.","Diaz previously served as president and CEO of Myriad Genetics and, before that, as president and CEO of Kindred Healthcare.","He also sits on the board of Centene Corporation, the Board of Trustees of Johns Hopkins Medicine and the Board of Visitors of Georgetown University Law Center.","With Diaz's addition the Merck board will consist of 14 members; he receives standard non-employee director compensation."],"urls":{"canonical":"https://secwatch.observer/filing/0000310158-26-000237","json":"https://secwatch.observer/filing/0000310158-26-000237.json","markdown":"https://secwatch.observer/filing/0000310158-26-000237.md","text":"https://secwatch.observer/filing/0000310158-26-000237.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/310158/000031015826000237/0000310158-26-000237-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/310158/000031015826000237/mrk-20261009.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-13T16:38:02.826162+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6d44750b00","claim":"Paul J. Diaz was elected as Director at Merck & Co., Inc..","evidence_excerpt":"Incorporated by reference is a press release issued by Merck & Co., Inc. (the “Company) on October 13, 2026, attached as Exhibit 99.1, announcing the election of Paul J. Diaz to the Company’s Board of Directors (the “Board”), effective November 1, 2026.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/310158/000031015826000237/0000310158-26-000237-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}